These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 1673149)

  • 21. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
    Makrigiannis AP; Hoskin DW
    J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic T lymphocyte unresponsiveness induced by prolonged treatment with immobilized anti-CD3 antibody. Association of impairment of cytolytic activity with temporary depletion of intracellular protein kinase C.
    Sano S; Kiyotaki C; Tatsumi Y; Fujiwara H; Hamaoka T
    J Immunol; 1989 Nov; 143(9):2797-805. PubMed ID: 2530277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
    Arancia G; Malorni W; Donelli G
    Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perforin expression in human peripheral blood mononuclear cells. Definition of an IL-2-independent pathway of perforin induction in CD8+ T cells.
    Lu P; Garcia-Sanz JA; Lichtenheld MG; Podack ER
    J Immunol; 1992 Jun; 148(11):3354-60. PubMed ID: 1588036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
    Williams NS; Engelhard VH
    J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells.
    Smyth MJ; Ortaldo JR; Bere W; Yagita H; Okumura K; Young HA
    J Immunol; 1990 Aug; 145(4):1159-66. PubMed ID: 2143209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y; Thoburn CJ; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes.
    Berke G; Rosen D; Ronen D
    Immunology; 1993 Jan; 78(1):105-12. PubMed ID: 8436395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perforin mRNA in primary peritoneal exudate cytotoxic T lymphocytes.
    Nagler-Anderson C; Lichtenheld M; Eisen HN; Podack ER
    J Immunol; 1989 Dec; 143(11):3440-3. PubMed ID: 2584700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity in direct cytotoxic function of L3T4 T cells. TH1 clones express higher cytotoxic activity to antigen-presenting cells than TH2 clones.
    Chang JC; Zhang L; Edgerton TL; Kaplan AM
    J Immunol; 1990 Jul; 145(2):409-16. PubMed ID: 1973181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.
    Johnson BJ; Costelloe EO; Fitzpatrick DR; Haanen JB; Schumacher TN; Brown LE; Kelso A
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2657-62. PubMed ID: 12601154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Avidity dictates the lytic capacity of human cytolytic T lymphocyte clones with similar fine specificity against murine cells expressing HLA-B27 antigen.
    Calvo V; Rojo S; Aparicio P; Galocha B; López de Castro JA
    J Immunol; 1988 Dec; 141(11):3798-803. PubMed ID: 2460549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells.
    Williams NS; Engelhard VH
    J Immunol; 1997 Sep; 159(5):2091-9. PubMed ID: 9278294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic inhibitors distinguish cytolytic activity of CD4 and CD8 clones.
    Strack P; Martin C; Saito S; Dekruyff RH; Ju ST
    Eur J Immunol; 1990 Jan; 20(1):179-84. PubMed ID: 1968392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway.
    Isaaz S; Baetz K; Olsen K; Podack E; Griffiths GM
    Eur J Immunol; 1995 Apr; 25(4):1071-9. PubMed ID: 7737276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An ovalbumin peptide-specific cytotoxic T cell clone with antigen self-presentation capacity uses two distinct mechanisms to kill target cells.
    Dick T; Reichmann G; Ebnet K; Simon MM; Dienes HP; Echternacher B; Krammer PH; Reske-Kunz AB
    Cell Immunol; 1993 Dec; 152(2):333-47. PubMed ID: 8258142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation.
    Van de Wiel-van Kemenade E; Te Velde AA; De Boer AJ; Weening RS; Fischer A; Borst J; Melief CJ; Figdor CG
    Eur J Immunol; 1992 Jun; 22(6):1467-75. PubMed ID: 1376259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of two distinct cytolytic mechanisms among murine CD4 subsets.
    Ju ST; Ruddle NH; Strack P; Dorf ME; DeKruyff RH
    J Immunol; 1990 Jan; 144(1):23-31. PubMed ID: 1967264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
    J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional importance of CD4+ and CD8+ cells in cytotoxic lymphocytes activity and associated gene expression. Impact on the age-related decline in lytic activity.
    Bloom ET
    Eur J Immunol; 1991 Apr; 21(4):1013-7. PubMed ID: 1673431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.